| Study ID | Study follow‐up (months) | CVnCoV (n) | Placebo (n) | Important outcomes | ||
| GMT of specific antibody against 2019 novel coronavirus | GMT of neutralizing antibody against 2019 novel coronavirus | Local reactogenicity events | ||||
| Kremsner 2021 (NCT04652102; EudraCT 2020‐003998‐22) | 6.23 | 19,783 | 19,746 | * | * | ✓ |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.